Gastrointestinal Drugs Market - Irritable Bowel Syndrome and Functional GI Disorders
Market Overview The global Gastrointestinal Drugs Market is experiencing explosive growth driven by inflammatory bowel disease demand, immunomodulation advancement, and biologic therapy expansion. The global gastrointestinal drugs market is projected to exceed USD 30 billion through 2030, fueled by anti-TNF biosimilar adoption, vedolizumab growth, and ustekinumab expansion. Gastrointestinal...
0 Commentarii 0 Distribuiri 240 Views 0 previzualizare
social art-inpa https://social.art-inpa.com